We compared invasive cervical cancer (ICC) incidence rates in Europe, South Africa, Latin
and North America among women living with HIV who initiated antiretroviral therapy (ART) …

Objectives We examined trends in the incidence rates of invasive cervical cancer (ICC) and
in the rate of survival after ICC among women living with HIV (WLHIV) in France and …

Data on invasive cervical cancer (ICC) incidence in HIV‐positive women and the effect of
cervical cancer screening in sub‐Saharan Africa are scarce. We estimated i) ICC incidence …

Although invasive cervical cancer (ICC) has been included among the AIDS‐defining
conditions since 1993, it remains controversial whether HIV infection increases the risk of …

Background HIV enhances human papillomavirus (HPV)-induced carcinogenesis. However,
the contribution of HIV to cervical cancer burden at a population level has not been …

Objective (s) To evaluate the frequency and correlates of invasive cervical cancer (ICC) as
an AIDS-defining illness (ADI) in Europe. Design Statistical analysis of data from: national …

To estimate the incidence of invasive cervical cancer (ICC) across up to 21 years of follow‐
up among women with human immunodeficiency virus (HIV) and to compare it to that among …

BACKGROUND: The objective of this study was to estimate the incidence of invasive
cervical cancer (ICC) in women with human immunodeficiency virus (HIV) and compare it …

HIV substantially worsens human papillomavirus (HPV) carcinogenicity and contributes to
an important population excess of cervical cancer, particularly in sub‐Saharan Africa (SSA) …

Objective: To measure the incidence of invasive cervical cancer (ICC) in US women infected
with HIV. Design: Multicenter prospective cohort study, conducted between October 1994 …